Literature DB >> 7226495

Laser nephelometry of orosomucoid in serum of newborns: reference intervals and relation to bacterial infections.

J Bienvenu, L Sann, F Bienvenu, C Lahet, P Divry, J Cotte, M Bethenod.   

Abstract

Orosomucoid was evaluated by laser-nephelometry in 1790 sera collected from 1170 newborns. Within-run precision (CV) was 2.1 to 4.2%, between-run 2.9 to 5.2%. Results correlated well with radial immunodiffusion (r = 0.989). Results can be obtained within 1 h. Orosomucoid concentrations in serum at birth range from 130 to 200 mg/L and are influenced by gestational age during the first two days of postnatal life. Thereafter, the values increase very rapidly in the first week of life, concentrations being the same as in adults by about 10 months. In 66 of 78 cases of severe bacterial infections, orosomucoid concentrations were above normal. Evidently, serum orosomucoid constitutes an useful index in diagnosis and monitoring of bacterial infections in the neonatal period.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7226495

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  Reference distributions for the positive acute phase proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a comparison of a large cohort to the world's literature.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 2.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

3.  Acute phase proteins for diagnosis and follow-up of neonatal infections.

Authors:  L Sann
Journal:  Indian J Pediatr       Date:  1986 Jan-Feb       Impact factor: 1.967

4.  Crohn's disease and vitamin B12 metabolism.

Authors:  D Lambert; S Benhayoun; C Adjalla; M A Gelot; P Renkes; F Felden; P Gerard; F Belleville; P Gaucher; J L Guéant; J P Nicolas
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

5.  Transglutaminases in Crohn's disease.

Authors:  G D'Argenio; L Biancone; V Cosenza; N Della Valle; F P D'Armiento; M Boirivant; F Pallone; G Mazzacca
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

6.  Lactoferrin in relation to acute phase proteins in sera from newborn infants with severe infections.

Authors:  T J Gutteberg; B Haneberg; T Jørgensen
Journal:  Eur J Pediatr       Date:  1984-04       Impact factor: 3.183

7.  Alpha 1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy.

Authors:  M Contin; R Riva; F Albani; E Perucca; G Lamontanara; A Baruzzi
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected Subjects.

Authors:  Anil R Maharaj; Daniel Gonzalez; Michael Cohen-Wolkowiez; Christoph P Hornik; Andrea N Edginton
Journal:  Clin Pharmacokinet       Date:  2018-05       Impact factor: 5.577

Review 9.  Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein.

Authors:  Sherri A Smith; Nigel J Waters
Journal:  Pharm Res       Date:  2018-12-28       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.